STEVENS CAPITAL MANAGEMENT LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 170 filers reported holding HAEMONETICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2019$391,000
-83.5%
3,404
-87.4%
0.04%
-63.4%
Q1 2019$2,365,000
+68.1%
27,030
+92.3%
0.10%
+40.3%
Q4 2018$1,407,000
-54.6%
14,059
-59.4%
0.07%
-35.1%
Q2 2018$3,102,000
+948.0%
34,594
+579.9%
0.11%
+909.1%
Q4 2017$296,000
-37.0%
5,088
-51.5%
0.01%
-35.3%
Q3 2017$470,000
-57.1%
10,480
-62.2%
0.02%
-58.5%
Q2 2017$1,096,000
+206.1%
27,744
+214.2%
0.04%
+192.9%
Q1 2017$358,000
+63.5%
8,830
+61.9%
0.01%
+55.6%
Q4 2016$219,000
-0.9%
5,455
-28.5%
0.01%0.0%
Q2 2016$221,000
-70.1%
7,631
-63.9%
0.01%
-69.0%
Q1 2016$740,000
+142.6%
21,161
+123.5%
0.03%
+141.7%
Q4 2015$305,000
-59.0%
9,470
-58.8%
0.01%
-64.7%
Q3 2015$743,000
-20.6%
22,987
+1.5%
0.03%0.0%
Q2 2015$936,000
+208.9%
22,639
+235.2%
0.03%
+209.1%
Q1 2015$303,000
+9.8%
6,753
-20.1%
0.01%
+57.1%
Q1 2014$276,000
-50.1%
8,457
-39.0%
0.01%
-56.2%
Q3 2013$553,00013,8690.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders